Last $0.05 USD
Change Today 0.00 / 0.00%
Volume 0.0
ICOTF On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew J. Rae BSc, MBA

Co-Founder, Chief Executive Officer, President, Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee, iCo Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 4 different industries.

See Board Relationships
47C$472,843
As of Fiscal Year 2013

Background*

Mr. Andrew J. Rae, BSc, MBA co-founded ICo Therapeutics Inc. in 2005 and serves as its Chief Executive Officer and President since February 2005. Mr. Rae serves as a Consultant to Ventures West Management. He has a decade of experience in the biotechnology field. Mr. Rae served as the Chief Financial Officer of Ability Biomedical Corp. of Irvine, California and Vancouver, British Columbia and as its Chief Executive Officer since February 2005. He served as Vice-President ...

Read Full Background

Corporate Headquarters*

760-777 Hornby Street
Vancouver, British Columbia V6Z 1S4

Canada

Phone: 604-602-9414
Fax: 604-602-9699

Board Members Memberships*

2005-Present
Co-Founder, Chief Executive Officer, President, Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee
2006-2007
Former Director and Member of Audit Committee
2008-N/A
Former Director, Member of Audit Committee and Member of Compensation & Corporate Governance Committee
2010-N/A
Former Director, Member of Audit Committee and Member of Compensation & Corporate Governance Committee

Education*

BS
The University Of Western Ontario
MBA
Simon Fraser University

Other Affiliations*

Annual Compensation*

SalaryC$234,713
Total Annual CompensationC$234,713

Stock Options*

All Other CompensationC$3,630
Total Number of Options840,000

Total Compensation*

Total Annual Cash CompensationC$238,343
Total Short Term CompensationC$234,713
Other Long Term CompensationC$3,630
Total Calculated CompensationC$472,843
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICOTF:US $0.05 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.